Curability Difference between Autochthonous Mouse Tumors and Their Transplants in Association with Immune Gene Expression
Hiroshi TanookaiD, Chie Kudo-Saito, Fumiko ChiwakiiD, Masamichi IshiaiiD, Kouichi Tatsumi, Hiroki Sasaki, Takahiro OchiyaiD
Abstract
Compared with transplanted tumors, autochthonous tumors are difficult to cure by experimental radiation therapy in mice. Here we analyzed differences in immune gene expression profiles between mouse fibrosarcomas subcutaneously induced by 3-methylcholanthrene (3MC) and their transplants. The immune genes examined were pd1, pdl1, pdl2, cd3d, cd8a, cd8b, ifn{gamma}, dx5, grzmb, and foxp3. Among 12 tumors, one was non-transplantable and showed a benign character with an abundance of DX5+ natural killer cells and CD8+ T cells together with increased IFN{gamma} expression. The other 11 transplantable tumors showed increased expression of pd1, pdl1, pdl2, cd3d, and cd8b, after their transplantation into syngeneic mice. These effects of transplantation highlight the relevance of immune gene expression status to the curability of tumors.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 0th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A single cell atlas reveals distinct immune landscapes in transplant and primary tumors that determine response or resistance to immunotherapy
A. J. Wisdom, Y. M. Mowery, … D. G. Kirsch·bioRxiv·Mar 11, 2020
- Autologous humanized mouse models of iPSC-derived tumors allow for the evaluation and modulation of cancer-immune cell interactions
G. Moquin-Beaudry, B. Benabdalah, … C. Beausejour·bioRxiv·Apr 2, 2021
- Differential Impact of Lymphocytes on Radiation Response in Autochthonous versus Transplant Sarcomas in Syngeneic Mice
Yvonne Marie Mowery, Aastha Sobti, … David G. Kirsch·bioRxiv·Oct 5, 2025
- NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers
C. E. B. Ong, A. L. Patchett, … A. S. Flies·bioRxiv·Sep 6, 2020
- Both CD8 and CD4 T cells contribute to immunosurveillance preventing the development of neoantigen-expressing autochthonous sarcomas
J. E. Himes, A. J. Wisdom, … D. G. Kirsch·bioRxiv·Apr 4, 2023
- Temporal genomic analysis of melanoma rejection identifies regulators of tumor immune evasion
S. C. Shvefel, J. Pai, … Y. Samuels·bioRxiv·Nov 29, 2023